Publication | Open Access

Persistence of Lymphocytotoxic Antibodies in Patients in the Trial to Reduce Alloimmunization to Platelets: Implications for Using Modified Blood Products

Lymphocytotoxic AntibodiesThrombosisThrombopoiesisAutoimmune DiseaseModified Blood ProductsBlood PlateletImmunologyHematologyPlatelet AntagonistAutoimmunityImmunotherapyMedicineAnticoagulantBlood Transfusion